Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

PolandBack to Poland

Clinical trials in Węgrów

2 clinical trials in Węgrów, Poland. Every trial is listed in the EU Clinical Trials Register and updated daily.

PolandOur site in PolandBadaniaKliniczne.pl(opens in a new tab)
Węgrów at a glance
2
clinical trials
  • Recruiting now0
  • Not yet recruiting0
  • Paediatric trials0
  • Research sites0
Type of trial
Recruitment status
Quick filters

2 trials in Węgrów

Open in trial search

Dyslipidaemia

Not recruiting
Registered drug
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Evolocumab
  • Sponsor:Amgen Inc.

Chronic kidney disease+1

Not recruiting
Investigational
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Ziltivekimab
  • Sponsor:Novo Nordisk A/S

Other cities in Poland

The busiest research cities in the country

All 239 cities in Poland

Clinical research in Węgrów

What the registry says about research in the country

01 Węgrów
Cardiovascular Diseases
Clinical research in Węgrów is focused on cardiovascular diseases, with studies looking at ways to lower the risk of major heart and stroke-related events in adults who are already at high risk. Adults at high risk of cardiovascular events without prior myocardial infarction or stroke Atherosclerotic cardiovascular disease and related heart complications Evaluating a treatment approach intended to reduce the chance of serious cardiovascular outcomes These trials aim to improve prevention strategies for people receiving standard lipid-lowering care.
Nutritional and Metabolic Diseases
Another key area is nutritional and metabolic diseases, with research centered on patients who have chronic kidney disease alongside inflammation and established cardiovascular problems. Chronic kidney disease combined with systemic inflammation People with established atherosclerotic cardiovascular disease Testing whether a new therapy can better reduce the risk of major adverse cardiovascular events The studies explore whether adding a new treatment can offer better protection than placebo when used with current standard care.
Back to PolandAll countries
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.